Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P70
Within normal range
Average
-1298.31%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | +100.0% |
| 2021 | -6164.17% | -100.4% |
| 2020 | -3076.17% | -1355.9% |
| 2019 | -211.28% | +81.9% |
| 2018 | -1166.54% | +11.9% |
| 2017 | -1323.96% | -27.2% |
| 2016 | -1040.97% | - |